Requip for Consumers: Requip / Requip XL

More information on Restless Legs Syndrome

Restless Legs Syndrome (RLS) affects up to 10% of American adults. They may have difficulty lying down and sleeping, or sitting down and relaxing, because their legs just won't let them. Air travel and long car trips are a trial. Even enjoying a television show may be more than they can manage.

For complete Product Information about Requip^® (ropinirole), click here.

Requip XL (ropinirole extended-release tablets) CLICK HERE

REQUIP XL is indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. Learn more about REQUIP XL for Parkinson’s disease >

^*For the signs and symptoms of idiopathic Parkinson’s disease

IMPORTANT NOTE: REQUIP XL has not been studied in Restless Legs Syndrome (RLS) and is not approved for the treatment of RLS. However, an immediate-release form of ropinirole (REQUIP) is approved for the treatment of RLS.

Important Safety Information:

Prescription REQUIP XL is not for everyone. REQUIP XL may cause you to fall asleep or feel very sleepy during normal activities such as driving; or to faint or feel dizzy, nauseated, or sweaty when you stand up. Tell your doctor if you experience these or the following problems, or if you drink alcohol or are taking other medicines that make you drowsy. Side effects may include nausea, dizziness, drowsiness or sleepiness, headache, and sudden uncontrolled movements (dyskinesia). Increase or decrease in blood pressure and heart rate may occur. Hallucinations may occur at any time during treatment. Also tell your doctor if you experience new or increased gambling, sexual, or other intense urges while taking REQUIP XL. REQUIP XL may increase the side effects of
L-dopa. Most patients were not bothered enough to stop taking REQUIP XL.

For more Product Information about REQUIP XL, click here.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.